tiprankstipranks
Advertisement
Advertisement

VCYT Stock Latest News

Veracyte: Leveraging TrueMRD and Decipher Bladder to Capture a $200M Minimal Residual Disease Opportunity
RatingsVeracyte: Leveraging TrueMRD and Decipher Bladder to Capture a $200M Minimal Residual Disease Opportunity
9d ago
VCYT
Veracyte price target lowered to $45 from $50 at Guggenheim
PremiumThe Fly
Veracyte price target lowered to $45 from $50 at Guggenheim
11d ago
VCYT
Veracyte Appoints Kevin Haas as Chief Technology Leader
PremiumCompany Announcements
Veracyte Appoints Kevin Haas as Chief Technology Leader
24d ago
8K
VCYT
Veracyte names Kevin Haas as Chief Development and Technology Officer
PremiumThe Fly
Veracyte names Kevin Haas as Chief Development and Technology Officer
24d ago
VCYT
Veracyte price target lowered to $37 from $48 at Morgan Stanley
PremiumThe Fly
Veracyte price target lowered to $37 from $48 at Morgan Stanley
1M ago
VCYT
Veracyte Inc. Signals Durable Growth in Earnings Call
PremiumCompany AnnouncementsVeracyte Inc. Signals Durable Growth in Earnings Call
1M ago
VCYT
Veracyte: Accelerating Growth, Expanding Margins, and Pipeline-Driven Upside Support a Raised $48 Price Target
Premium
Ratings
Veracyte: Accelerating Growth, Expanding Margins, and Pipeline-Driven Upside Support a Raised $48 Price Target
1M ago
VCYT
Veracyte reports Q4 EPS 51c, consensus 41c
Premium
The Fly
Veracyte reports Q4 EPS 51c, consensus 41c
1M ago
VCYT
Veracyte sees FY26 revenue $570M-$582M, consensus $570.3M
PremiumThe Fly
Veracyte sees FY26 revenue $570M-$582M, consensus $570.3M
1M ago
VCYT
VCYT Earnings this Week: How Will it Perform?
PremiumPre-Earnings
VCYT Earnings this Week: How Will it Perform?
2M ago
VCYT
Cathie Wood Buys the Dip in Joby Aviation (JOBY), Sells Teradyne (TER) Near Highs
PremiumMarket News
Cathie Wood Buys the Dip in Joby Aviation (JOBY), Sells Teradyne (TER) Near Highs
2M ago
TER
ARKQ
Cathie Wood Invests Over $3M Into Crypto Stock, Trims Stakes in Kratos Defense and TWST
PremiumMarket News
Cathie Wood Invests Over $3M Into Crypto Stock, Trims Stakes in Kratos Defense and TWST
2M ago
KDK
BLSH
Veracyte: Strong Fundamentals and Margin Profile Offset by Execution Risks and Limited Valuation Upside, Justifying Hold Rating
PremiumRatingsVeracyte: Strong Fundamentals and Margin Profile Offset by Execution Risks and Limited Valuation Upside, Justifying Hold Rating
2M ago
VCYT
Veracyte: Strong Near-Term Performance but Execution and Valuation Risks Justify Sell Rating
Premium
Ratings
Veracyte: Strong Near-Term Performance but Execution and Valuation Risks Justify Sell Rating
3M ago
VCYT
Veracyte reports preliminary Q4 revenue $138M-$140M, consensus $131.75M
Premium
The Fly
Veracyte reports preliminary Q4 revenue $138M-$140M, consensus $131.75M
3M ago
VCYT
Veracyte sees FY26 revenue $570M-$582M, consensus $565.76M
PremiumThe Fly
Veracyte sees FY26 revenue $570M-$582M, consensus $565.76M
3M ago
VCYT
Veracyte price target raised to $50 from $45 at Guggenheim
PremiumThe Fly
Veracyte price target raised to $50 from $45 at Guggenheim
3M ago
VCYT
Veracyte assumed with an Underweight at Morgan Stanley
PremiumThe Fly
Veracyte assumed with an Underweight at Morgan Stanley
4M ago
VCYT
Veracyte price target raised to $40 from $28 at Morgan Stanley
PremiumThe Fly
Veracyte price target raised to $40 from $28 at Morgan Stanley
5M ago
VCYT
NCCN guidelines incrementally favorable for Veracyte’s Decipher, says Guggenheim
PremiumThe FlyNCCN guidelines incrementally favorable for Veracyte’s Decipher, says Guggenheim
5M ago
VCYT
Veracyte Inc. Reports Robust Q3 Earnings Performance
Premium
Company Announcements
Veracyte Inc. Reports Robust Q3 Earnings Performance
5M ago
VCYT
Veracyte rises 21.4%
Premium
The Fly
Veracyte rises 21.4%
5M ago
VCYT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >